Alzheimer's Disease: Reducing the burden with ApoE2

被引：0
|
作者：
H J Federoff
机构：
[1] University of Rochester School of Medicine and Dentistry,Center for Aging and Developmental Biology, Aab Institute of Biomedical Sciences
来源：
Gene Therapy | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1019 / 1020
页数：1
相关论文
共 50 条
  • [41] APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease
    Jackson, Rosemary J.
    Keiser, Megan S.
    Meltzer, Jonah C.
    Fykstra, Dustin P.
    Dierksmeier, Steven E.
    Hajizadeh, Soroush
    Kreuzer, Johannes
    Morris, Robert
    Melloni, Alexandra
    Nakajima, Tsuneo
    Tecedor, Luis
    Ranum, Paul T.
    Carrell, Ellie
    Chen, Yonghong
    Nishtar, Maryam A.
    Holtzman, David M.
    Haas, Wilhelm
    Davidson, Beverly L.
    Hyman, Bradley T.
    MOLECULAR THERAPY, 2024, 32 (05) : 1373 - 1386
  • [42] Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention
    Keeney, Jeriel Thomas-Richard
    Ibrahimi, Shaher
    Zhao, Liqin
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (02) : 411 - 424
  • [43] Suppression of Neurological Deterioration in the APP1.PSEN1/APOE4 Murine Model of Alzheimer's Disease by AAV-Mediated Expression of APOE2 Christchurch
    Gunaydin, Caner
    Lephart, Hailey C.
    Stiles, Katie M.
    Hackett, Neil R.
    Kaminsky, Stephen M.
    Sondhi, Dolan
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2023, 31 (04) : 402 - 403
  • [44] APOE2 allele increased in tardive dyskinesia
    Halford, J
    Mazeika, G
    Slifer, S
    Speer, M
    Saunders, AM
    Strittmatter, WJ
    Morgenlander, JC
    MOVEMENT DISORDERS, 2006, 21 (04) : 540 - 542
  • [45] No association of CSF biomarkers with APOEε4, plaque and tangle burden in definite Alzheimer's disease
    Engelborghs, Sebastiaan
    Sleegers, Kristel
    Cras, Patrick
    Brouwers, Nathalie
    Serneels, Sally
    De Leenheir, Evelyn
    Martin, Jean-Jacques
    Vanmechelen, Eugeen
    Van Broeckhoven, Christine
    De Deyn, Peter Paul
    BRAIN, 2007, 130 : 2320 - 2326
  • [46] LDL METABOLISM IN NORMOLIPIDEMIC APOE2 HOMOZYGOTES
    GREGG, RE
    ZECH, LA
    GABELLI, C
    STARK, D
    WILSON, D
    BREWER, HB
    CIRCULATION, 1984, 70 (04) : 312 - 312
  • [47] Synergism of ApoE4 and systemic infectious burden is mediated by the APOE-NLRP3 axis in Alzheimer's disease
    Liu, Xue-Ting
    Chen, Xiu
    Zhao, Na
    Geng, Fan
    Zhu, Meng-Meng
    Ren, Qing-Guo
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (09) : 517 - 526
  • [48] S-Nitrosylation of ApoE in Alzheimer's Disease
    Abrams, Alexander J.
    Farooq, Amjad
    Wang, Gaofeng
    BIOCHEMISTRY, 2011, 50 (17) : 3405 - 3407
  • [49] APOE and metabolic dysfunction in Alzheimer's disease
    Johnson, Lance A.
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 131 - 151
  • [50] The ApoE gene of Alzheimer's disease (AD)
    P. K. Krishnan Namboori
    K. V. Vineeth
    V. Rohith
    Ibnul Hassan
    Lekshmi Sekhar
    Akhila Sekhar
    M. Nidheesh
    Functional & Integrative Genomics, 2011, 11 : 519 - 522
12345